Filgrastim post-chemotherapy mobilizes more CD34+ cells compared to its use during steady-state haemopoiesis [3]

1. Perez-Oteyza, J.
2. Garcia-Larana, J.
3. Ramos, P.
4. Zamora, C.
5. Lopez-Jimenez, J.
6. Roldan, E.
7. Odriozola, J.